Belimumab/guselkumab

Crohn's-disease and inflammatory bowel disease: 2 case reports

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      "Country of occurrence, reporter country and primary source country not stated."

    Reference

    1. Hashmi S, et al. DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE (IBD) FOLLOWING THE USE OF BIOLOGIC TREATMENT FOR RHEUMATOLOGIC DISEASES: A REVIEW OF THE FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTS SYSTEM (FAERS). Gastroenterology 158 (Suppl. 1): S-959-S-960 abstr. Mo1879, No. 6, May 2020. Available from: URL: http://doi.org/10.1016/S0016-5085%2820%2933076-6 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Belimumab/guselkumab. Reactions Weekly 1809, 65 (2020). https://doi.org/10.1007/s40278-020-79849-4

    Download citation